Decalin derivatives, a process for the preparation and pharmaceutical composition thereof

US11724995B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11724995-B2
Application numberUS-201917287404-A
CountryUS
Kind codeB2
Filing dateOct 22, 2019
Priority dateOct 22, 2018
Publication dateAug 15, 2023
Grant dateAug 15, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Decalin derivative compounds of formula (I) are provided, including processes for preparation thereof, and pharmaceutical compositions including the decalin derivative compounds. Methods are provided for treating blood related disorders, such as sickle cell anemia, in a subject in need thereof using a compound of formula (I).

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing a decalin derivative compound of formula (A8): where: R 1 , R 2 , R 4 , and R 5 , are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, the process comprising: (a) protecting and following allylic oxidation of a compound according to formula (A5): where R 6 is hydrogen, to afford a compound according to formula (A6): (b) epoxidating and deprotecting the compound according to formula (A6) to afford a compound according to formula (A7): and (c) reducing the compound according to formula (A7) to afford the compound according to formula (A8), wherein: R 1 , R 2 , R 4 , and R 5 in formulas (A5), (A6), (A7) are as defined in the compound of formula (A8); and Pg in the compounds of formulas (A6) and (A7) is a protecting group. 2. A process for the preparation of a decalin derivative compound of formula (A13): where: R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 are independently chosen from: hydrogen; or unsubstituted C1-C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, or wherein R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 may be joined to form an unsubstituted or substituted fused cyclic ring, and represents a single or double bond, the process comprising: (a) halogenating a compound according to formula (A9): to afford a compound according to formula (A10): where X is a halogen; (b) performing Suzuki Coupling on the compound according to formula (A10) in the presence of a compound according to formula (X): to afford a compound according to formula (A11): (c) forming an epoxide on the compound according to formula (A11) to afford a compound according to formula (Al2): and (d) reducing the compound according to formula (Al2) to afford the compound according to formula (A13), wherein: R 1 , R 2 , R 4 , R 5 , R 7 , and R 9 in of formulas (A9), (A10), (X), (A11), (Al2) are as defined in formula (A13). 3. A process for preparing a decalin derivative compound of formula (A21): where: R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, and wherein any of R 1 , R 2 , R 4 , R 5 , R 7 , or R 10 may be joined to form an unsubstituted or substituted fused cyclic ring, the process comprising: (a) undergoing ozonolysis on a compound according to formula (A14): to afford a compound according to formula (A15): (b) rearranging the compound according to formula (A15) to afford a compound according to formula (A16): (c) reducing and protecting the compound according to formula (A16) to afford a compound according to formula (A17): where R 9 is independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS, or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine; (d) epoxidating and reducing the compound according to formula (A17) to afford a compound according to formula (A18): (e) oxidating, deprotecting, and rearranging the compound according to formula (A18), to afford a compound according to formula (A19): hydrogenating the compound according to formula (A19) to afford a compound according to formula (A20): and (g) oxidating the compound according to formula (A20) to afford the compound according to formula (A21), wherein: R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 in the compounds of formulas (A14), (A15), (A16), (A17), (A18), (A19), and (A20), are as defined in the compound of formula (A21); and TBS in formulas (A17) and (A18) is tert-butyldimethylsilyl. 4. A process for preparing a decalin derivative compound of formula (A23) or formula (A25): where: R′, R 2 , R 4 , R 5 , R 7 , and R 10 are independently chosen from: hydrogen; or unsubstituted C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl; or unsubstituted C 2 -C 10 alkenyl or C 2 -C 10 alkenyl substituted with hydroxy, alkoxy, ester, or —OTBS; or amino, halo, hydroxyl, carbonyl, thiocarbonyl, carboxylate, alkoxy, carbamide, carbamate, or hydrazine, wherein any of R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 may be joined to form an unsubstituted or substituted fused cyclic ring, the process comprising: dihydroxylating a compound according to formula (A22): wherein R 6 is hydrogen and wherein R 1 , R 2 , R 4 , R 5 , R 7 , and R 10 in formula (A22) are as defined in the compound according to formula (A23) to afford the compound according to formula (A23); or dihydroxylating a compound according to formula (A24): wherein R

Assignees

Inventors

Classifications

  • C07D303/32Primary

    by aldehydo- or ketonic radicals · CPC title

  • containing rings other than six-membered aromatic rings · CPC title

  • containing hydroxy groups · CPC title

  • containing ether groups, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] groups · CPC title

  • C07C49/733Primary

    having two rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11724995B2 cover?
Decalin derivative compounds of formula (I) are provided, including processes for preparation thereof, and pharmaceutical compositions including the decalin derivative compounds. Methods are provided for treating blood related disorders, such as sickle cell anemia, in a subject in need thereof using a compound of formula (I).
Who is the assignee on this patent?
Council Scient Ind Res
What technology area does this patent fall under?
Primary CPC classification C07D303/32. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).